Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505140 · ClinicalTrials.gov registry record · Phase 2
Benefits of Walnuts for Male Reproductive Health
A Phase 2 study of Infertility and Nutrition Disorders, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01505140 is a Phase 2 study of Infertility and Nutrition Disorders that has completed, run by University of California, Los Angeles. The registered enrollment target is 120 participants, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01505140, a Phase 2 study of Infertility and Nutrition Disorders, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Walnuts as a whole food contain polyunsaturated fatty acids, anti-oxidants, and other nutrients essential to sperm development and function. This randomized controlled trial sought to determine if a Western style diet supplemented with walnuts would improve sperm quality as a predictor of male fertility.
Conditions Studied
Interventions
- OTHER Whole walnuts
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01505140
The ClinicalTrials.gov registry entry for NCT01505140 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,588-participant average among 74 other Infertility trials with a reported enrollment target (98% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which Whole walnuts is the first listed.
NCT01505140 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01505140 about?
NCT01505140 is a clinical study titled "Benefits of Walnuts for Male Reproductive Health". Walnuts as a whole food contain polyunsaturated fatty acids, anti-oxidants, and other nutrients essential to sperm development and function. This randomized controlled trial sought to determine if a Western style diet supplemented with walnuts would improve sperm quality as a predictor of male ferti...
What is the current status of trial NCT01505140?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2009-11. Estimated completion is 2010-12.
What conditions does trial NCT01505140 study?
This clinical trial studies the following conditions: Infertility, Nutrition Disorders.
What interventions are being tested in trial NCT01505140?
The interventions under investigation include: Whole walnuts (OTHER).
Who is sponsoring clinical trial NCT01505140?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01505140 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)
COMPLETED · Phase 2
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
-
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RECRUITING · Phase 1
-
Non-Euploid Embryo Transfer (NEET) Registry
RECRUITING
-
Validating Incubators in the Lab: Optimizing Culture and Investigating blasTulation Yield
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.